×
Lucid Diagnostics Share Holder Equity 2021-2025 | LUCD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Lucid Diagnostics share holder equity from 2021 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
View More
Lucid Diagnostics Share Holder Equity 2021-2025 | LUCD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Lucid Diagnostics share holder equity from 2021 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$183.5B
Thermo Fisher Scientific (TMO)
$164.2B
Edwards Lifesciences (EW)
$45.8B
Alcon (ALC)
$43.1B
IDEXX Laboratories (IDXX)
$42.9B
DexCom (DXCM)
$32.7B
IQVIA Holdings (IQV)
$28.2B
Mettler-Toledo (MTD)
$25.4B
STERIS (STE)
$22.4B
Waters (WAT)
$21B
SONOVA HOLDING (SONVY)
$17.4B
Hologic (HOLX)
$14.6B
Sysmex ADR (SSMXY)
$10.6B
Penumbra (PEN)
$9.2B
Masimo (MASI)
$8.8B
Globus Medical (GMED)
$7.7B
Glaukos (GKOS)
$5.9B
Teleflex (TFX)
$5.1B
Integer Holdings (ITGR)
$4.2B
TransMedics (TMDX)
$3.8B
PROCEPT BioRobotics (PRCT)
$3.1B
LivaNova (LIVN)
$2.4B
Veracyte (VCYT)
$2.1B
Nihon Kohden (NHNKY)
$1.9B
Elekta AB (EKTAY)
$1.9B
Alphatec Holdings (ATEC)
$1.6B
Artivion (AORT)
$1.3B
Paragon 28 (FNA)
$1.1B
Pulse Biosciences (PLSE)
$1.1B
OPKO Health (OPK)
$1.1B